Bigbear Pharmaceutical·Medication Guide

• Exkivity Side Effects

  Get emergency medical help immediately if you have signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 190

• ​What should I avoid while taking Exkivity?

  Grapefruit may interact with Exkivity and cause side effects.Avoid eating grapefruit or drinking grapefruit juice products while taking this medicine.【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 189

• What if I miss a dose?

  Take the missed dose as soon as you remember. However, if it has been more than 6 hours since your scheduled dose, skip the missed dose. Do not take t···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 198

• How Effective is Mobocertinib? A Look at Clinical Trial Results for Exon 20+ NSCLC

  Mobotinib is an oral targeted therapy primarily used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC) harboring specific gen···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 182

• Living with Mobocertinib: A Patient’s Guide to Coping with Nausea and Skin Issues

  Mobocertinib is a targeted therapy for EGFRexon20 insertion-mutated non-small cell lung cancer. Common side effects include diarrhea, rash, stomatitis···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 183

• Does Insurance Cover Mobocertinib? Tips for Navigating Prior Authorization and Denials

  The price of mobotinib after reimbursement under China's national medical insurance varies depending on the specific circumstances. Choosing the g···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 188

• How Much Does Mobocertinib Cost? A Look at List Prices and Out-of-Pocket Expenses

  The specific price of Mobocertinib is currently affected by the purchase channel, regional policies, and medical insurance reimbursement. This drug mu···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 187

• 2026 Latest Global Price of Acalabrutinib

  Acalabrutinib is a vital targeted therapy for leukemia and lymphoma, with its price fluctuations and clinical guidelines remaining a focus of medical ···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 232

• Where is the most reliable place to buy Acalabrutinib

  Acalabrutinib is a critical targeted therapy for leukemia and lymphoma, and the reliability of your purchase channel directly impacts treatment outcom···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 237

• What is acalabrutinib used for

  Acalabrutinib is used for adult patients with:chronic lymphocytic leukemia (CLL)small lymphocytic lymphoma (SLL)mantle cell lymphoma (MCL) patientswho···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 238

• How does acalabrutinib work

  Cancer cells get signals to grow and divide from a protein called Bruton tyrosine kinase (BTK). Acalabrutinib mechanism of action is by blocking BTK t···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 233

• FDA Approves Calquence (acalabrutinib) for Adults with Mantle Cell Lymphoma

  October 31, 2017 -- The U.S. Food and Drug Administration today granted accelerated approval to Calquence (acalabrutinib) for the treatment of adults ···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 229

• FDA Approves Calquence for Adults with Chronic Lymphocytic Leukemia

  21 November 2019 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Calquence (acalabrutinib) for adult patien···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 220

• Calquence Plus Chemoimmunotherapy Approved in the U.S. for Patients with Previously Untreated Mantle

  17 January 2025 -- AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatmen···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 210

• Calquence Tablet Formulation Approved in the US Across Current indications

  Key Advantages of the New Tablet Formulation- New formulation can be co-administered with gastric acid-reducing agents- Tablet offers equivalent effic···【Read More】

  Update: 2026-02-26Source: Haiou HealthViews: 214